#40 ITW Sebastian Brunemeier - Biologist Expert in Geroscience, Serial Biotech Entrepeneur and VC Investor in Longevity Startups

ITW Sebastian Brunemeier - Biologist Expert in Geroscience, Serial Biotech Entrepreneur and VC Investor in Longevity StartupsIn this new episode of e², we have the pleasure to discuss with Sebastian Brunemeier, a brilliant and inspiring personality who has dedicated his life to extending the longevity of mankind.He is a biologist by training, an expert in geroscience (the science of ageing/longevity) and an expert in bio-business. Sebastian is a serial biotech entrepreneur and investor in the longevity field.Sebastian’s Linkedin: https://www.linkedin.com/in/sebastianaguiar/Sebastian’s Twitter: https://twitter.com/sebastian_geroKey points in Sebastian’s bio:Co-founder & General Partner at Healthspan Capital - https://www.healthspancapital.vc/Healthspan Capital is a seed fund supporting longevity and geroscience companies developing therapies that extend a healthy lifespan.Founder-CEO at ImmuneAGE PharmaDrug discovery platform for immune system rejuvenation.Founder-COO at Samsara Therapeutics a biopharmaceutical platform company aiming to discover first-in-class therapeutics that extend healthy lifespans. Samsara's platform is the largest-ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that extend a healthy lifespan and enhance autophagy.Co-Founder CIO at Cambrian BiopharmaCambrian Biopharma is a biotech venture capital holding company that helps scientists transmit their discoveries from the lab into the clinic. Cambrian has raised ±$160M since its founding, with >15 subsidiaries. Cambrian is uniquely focused on a specific field of biomedical research: the biology of ageing, also known as geroscience. Cambrian is built on an emerging business model that we call a ‘Distributed R&D Company’ or ‘DisCo’ that blends the best aspects of the venture capital firm with the capital-efficient, agile domain expertise of a mid-sized biotech company.Co-Founder CEO at Cyclone TherapeuticsCyclone Therapeutics is a preclinical-stage drug discovery company spun out of The Scripps Research Institute. The company is focused on enhancing protein quality control by modulating translation, based on an anti-inflammatory 'integrated stress response mimetic' MoA.Advisor at MoleculeA decentralized token exchange and licensing platform for biotech intellectual property. Originators of the VitaDAO decentralized financing platform for longevity biotech. Molecule aims to enable the funding of Academic research in ageing/longevity and other important health issues. For this, Molecule offers to tokenize the Academic IPs into IP-NFTs.---In this new episode, discover the journey of Sebastian Brunemeier from science to entrepreneurship and investment. Discover his Why, the driving force that nurtures Sebastian to make us live longer and healthier.Co-Host of this episode:Harold Knoll is a Sci-Tech curious and futurist, founder and CEO of DAYU a longevity startup that ambitions to tokenize our genes! https://www.linkedin.com/in/harold/https://twitter.com/HaroldKnollhttps://dayudna.io/---E² - Épistémê Entrepreneurhttps://www.episteme-entrepreneur.com/https://www.facebook.com/createurdefutur/https://twitter.com/createurdefutur--- Send in a voice message: https://anchor.fm/ari-massoudi/message Hosted on Acast. See acast.com/privacy for more information.